Home Cart Sign in  
Chemical Structure| 122955-42-4 Chemical Structure| 122955-42-4

Structure of XE991
CAS No.: 122955-42-4

Chemical Structure| 122955-42-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

XE991 is a potent and selective blocker of KV7 (KCNQ) voltage-gated potassium channels which blocks KV7.2+7.3 (KCNQ2+3) / M-currents (IC50 = 0.6 - 0.98 μM) and KV7.1 (KCNQ1) homomeric channels (IC50 = 0.75 μM) but is less potent against KV7.1/minK channels (IC50 = 11.1 μM).

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of XE991

CAS No. :122955-42-4
Formula : C26H20N2O
M.W : 376.45
SMILES Code : O=C1C2=C(C=CC=C2)C(CC3=CC=NC=C3)(CC4=CC=NC=C4)C5=CC=CC=C15
MDL No. :MFCD09055426

Safety of XE991

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CA1 pyramidal neurons 10 µM 10 minutes To study the effect of XE991 on synaptic transmission in CA1 pyramidal neurons, results showed that XE991 increased the frequency of sEPSCs but did not affect their amplitude. J Physiol. 2012 Aug 15;590(16):3953-64
Saos-2 cells 10 µM 14 days XE991 significantly promoted mineralization in Saos-2 cells, while the KV7 opener flupirtine reduced calcium deposits. Int J Mol Sci. 2016 Mar 18;17(3):407
MG-63 cells 10 µM 14 days XE991 increased matrix mineralization during osteoblast differentiation by inhibiting KV7.3 channels. Int J Mol Sci. 2016 Mar 18;17(3):407
CHO cells 10 µM 24 hours XE991 completely blocked caspase-3 activation induced by KCNQ2/3 channel expression, indicating that inhibition of KCNQ channels can prevent apoptosis. Cell Death Differ. 2011 Mar;18(3):493-505.
Hippocampal neurons 10 µM 24 hours XE991 significantly reduced NEM-induced cell death, indicating that inhibition of KCNQ channels can protect neurons from apoptosis. Cell Death Differ. 2011 Mar;18(3):493-505.
Porcine coronary artery smooth muscle cells 10 µM 30 minutes To investigate the effect of XE991 on hypoxia-induced vasodilation, results showed that XE991 significantly inhibited hypoxia-induced vasodilation Br J Pharmacol. 2014 Jan;171(1):69-82
Dorsal root ganglion neurons 10 µM 4 days To evaluate the effect of XE991 on axonal growth of DRG neurons, results showed XE991 tended to decrease axonal elongation. Int J Mol Sci. 2024 Jul 3;25(13):7327
Neocortical neurons 1-10 µM 48 hours To investigate the protective effect of XE991 on C2-ceramide-induced apoptosis, results showed XE991 had no protective effect. J Neurosci. 2002 Jan 1;22(1):114-22
Rat sympathetic neurons 5 µM 48-72 hours To investigate the protective effect of XE991 on NGF deprivation-induced apoptosis, results showed XE991 promoted neuronal survival in a concentration-dependent manner. J Neurosci. 2002 Jan 1;22(1):114-22
Mouse portal vein smooth muscle cells 10 µM 5 minutes To study the effect of XE991 on membrane potential, results showed XE991 depolarised the resting membrane potential and augmented the evoked response in a concentration-dependent manner. Br J Pharmacol. 2005 Oct;146(4):585-95
Mouse portal vein smooth muscle cells 5.8 µM (IC50) 5 minutes To study the inhibitory effect of XE991 on voltage-dependent potassium currents, results showed XE991 inhibited outward current in a concentration-dependent manner with an IC50 of 5.8 μM. Br J Pharmacol. 2005 Oct;146(4):585-95
HL-1 cells 100 µM 5.5 hours ischemia and 2 hours reperfusion Evaluate the effect of XE991 on HL-1 cell survival during simulated ischemia/reperfusion, showing cytoprotection when administered during ischemia or throughout the perfusion protocol Drug Des Devel Ther. 2020 Jul 2;14:2549-2560
Primary rat cortical neurons 10 µM 7 days XE991 reduced the burden of poly(GA)-EGFP aggregates and increased neuronal activity. EMBO Mol Med. 2021 Jul 7;13(7):e13131
HiPSC-derived C9orf72-mutant motoneurons 10 µM 7 days XE991 increased neuronal firing by inhibiting Kv7 channels, reduced aggregate burden, and restored CREB-dependent transcription and synaptic integrity. EMBO Mol Med. 2021 Jul 7;13(7):e13131

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Rest conditional knockout (cKO) mice Intraperitoneal injection 0.25 mg/kg and 0.5 mg/kg Single dose XE991 partially rescued hearing loss in Rest cKO mice Elife. 2022 Sep 20;11:e76754
Rat Isolated perfused rat heart model Perfusion 10 μM 25 min prior to ischemia and throughout the perfusion protocol Assess the impact of XE991 on infarct size and hemodynamic recovery, showing reduction in infarct size and improved recovery in all administration groups Drug Des Devel Ther. 2020 Jul 2;14:2549-2560
Mice TRPM8-deficient mice Topical application 10 μM Not specified To investigate the effect of XE991 on TRPM8-dependent cold sensing, it was found that XE991 failed to induce cold sensitization in TRPM8-deficient mice. J Neurosci. 2013 Oct 16;33(42):16627-41
Mice Freely moving awake mice Tracheal perfusion 10-30 μM 30 minutes Pretreatment with XE991 prevented retigabine from abolishing the α,β-MeATP-induced AP firing, indicating that XE991 affected the excitability of mouse lung nodose C-fiber terminals by blocking M-channels. JCI Insight. 2019 Mar 7;4(5):e124467
Mice Kv7.2(S559A) knock-in mice Intraperitoneal injection 2 mg/kg Single dose To evaluate the restorative effect of XE991 on long-term object recognition memory in Kv7.2(S559A) mice J Neurosci. 2020 Jul 22;40(30):5847-5856
Mice Hot-plate test model in freely moving mice Intrathalamic injection 2 mM, 300 nL Single injection, tested 20-60 minutes later XE991 decreased the pain threshold and reduced the latency of pain-related behavioral responses. Br J Pharmacol. 2015 Jun;172(12):3126-40
Rats Inflammatory pain model Subcutaneous injection 3 mg/kg Single dose Investigate the inhibitory effect of XE991 on APAP-induced analgesia Int J Mol Sci. 2022 Dec 30;24(1):650
Kv1.1-KO mice Kv1.1 knockout mice Intraperitoneal injection 5-10 mg/kg Single dose XE991 induced bilateral seizure/spreading depolarization complexes and death in Kv1.1-KO mice Brain. 2021 Oct 22;144(9):2863-2878
Rats Spontaneously hypertensive rats (SHRs) Microinjection into the central amygdala (CeA) 6.7 nmol Single injection, effects lasted approximately 26.8±3.9 minutes XE-991 increased arterial blood pressure (ABP) and renal sympathetic nerve activity (RSNA) in WKY rats but had no significant effect in SHRs. Cardiovasc Res. 2022 Jan 29;118(2):585-596
Borderline hypertensive rats (BHRs) Chronic unpredictable stress (CUS) model Bilateral CeA microinjection 6.7 nmol (in 50 nl aCSF into each side) Single injection XE-991 increased sympathetic outflow and blood pressure in unstressed BHRs but not in CUS-treated BHRs. Cardiovasc Res. 2023 Jul 6;119(8):1751-1762

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.66mL

0.53mL

0.27mL

13.28mL

2.66mL

1.33mL

26.56mL

5.31mL

2.66mL

References

 

Historical Records

Categories